Vimarsana
Biggest News Aggregation in the World

Page 12 - Aptar Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptar Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptar Pharma Today - Breaking & Trending Today

AptarGroup, Inc. (NYSE:ATR) Receives $140.00 Consensus PT from Brokerages - Vimarsana News

AptarGroup, Inc. (NYSE:ATR) Receives $140.00 Consensus PT from Brokerages

Shares of AptarGroup, Inc. (NYSE:ATR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the four analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month […]

Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site - Vimarsana News

Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site

Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site Aptar Mumbai to increase manufacturing capabilities in growing South East Asia market Crystal Lake, Illinois, December 7, 2023 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solut...

Aristotle Capital Boston LLC Purchases 5,421 Shares of AptarGroup, Inc. (NYSE:ATR) - Vimarsana News

Aristotle Capital Boston LLC Purchases 5,421 Shares of AptarGroup, Inc. (NYSE:ATR)

Aristotle Capital Boston LLC boosted its position in AptarGroup, Inc. (NYSE:ATR – Free Report) by 4.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 124,061 shares of the industrial products company’s stock after purchasing an additional 5,421 shares during the […]

Source: wkrb13.com
Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers - Vimarsana News

Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers

AptarGroup, Inc. , a global leader in drug and consumer product dosing, dispensing and protection technologies, is announcing a contract with the U.S. Food and Drug Administration to study the...

Panagora Asset Management Inc. Boosts Stake in AptarGroup, Inc. (NYSE:ATR) - Vimarsana News

Panagora Asset Management Inc. Boosts Stake in AptarGroup, Inc. (NYSE:ATR)

Panagora Asset Management Inc. raised its holdings in AptarGroup, Inc. (NYSE:ATR – Free Report) by 0.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,992 shares of the industrial products company’s stock after purchasing an additional 134 shares during the quarter. Panagora Asset Management […]

Source: wkrb13.com